MICA and cytomegalovirus infection: In addition to the well-known CMV high-risk sero-status or the application of lymphocyte-depleting induction therapies (p < 0.0001; hazard ratio HR = 8.73; 95% CI 3.2–24.0), the MICA rs2596538 G allele carrier status (p = 0.009; HR = 0.3; 95% CI 0.1–0.7) was confirmed as a novel significant-independent prognostic factor for CMV infection/disease during the first year after KTx.